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Abstract
Nyctalopin is a small leucine rich repeat proteoglycan (SLRP) whose function is critical for normal vision. The absence of
nyctalopin results in the complete form of congenital stationary night blindness. Normally, glutamate released by
photoreceptors binds to the metabotropic glutamate receptor type 6 (GRM6), which through a G-protein cascade closes the
non-specific cation channel, TRPM1, on the dendritic tips of depolarizing bipolar cells (DBCs) in the retina. Nyctalopin has
been shown to interact with TRPM1 and expression of TRPM1 on the dendritic tips of the DBCs is dependent on nyctalopin
expression. In the current study, we used yeast two hybrid and biochemical approaches to investigate whether murine
nyctalopin was membrane bound, and if so by what mechanism, and also whether the functional form was as a homodimer.
Our results show that murine nyctalopin is anchored to the plasma membrane by a single transmembrane domain, such
that the LRR domain is located in the extracellular space.
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Introduction
Nyctalopin is a small leucine rich repeat containing protein that
is required for normal vision [1,2] and is localized to the dendritic
tips of depolarizing bipolar cells (DBCs) [3]. It is predicted to be a
member of the small leucine rich proteoglycan (SLRP) family (for
review see [4]). The core of nyctalopin consists of eleven leucine
rich repeats (LRRs) that are capped at the N-terminus and the C-
terminus by cysteine rich motifs. The consensus LRR is 24 amino
acids with the sequence, x-x-I/V/L-x-x-x-x-F/P/L-x-x-L/P-x-x-
L-x-x-L/I-x-L-x-x-N-x-I/L, where x is any amino acid, and was
initially identified in the human alpha 2-glycoprotein [5]. The N-
and the C-terminal caps have a consensus arrangement of
Cx3Cx3CxCx6Cx3C and CCxCx19Cx23C, respectively. Each
tandem LRR domain is folded into b-sheets and a-helices joined
by loops. This arrangement of b-sheets and a-helices gives the
tandem LRR domain a horseshoe shape with parallel b-sheets
lining the concave side and a-helices lining the convex side (Figure
S1). At the N-terminus of nyctalopin there is a predicted signal
sequence. At the C-terminus of human nyctalopin there is a
consensus sequence for addition of a glycosylphosphatidylinositol
(GPI) anchor [1,2]. However, in mouse this site appears to be
absent, rather there may be one or more transmembrane domains
[6].
When expressed in heterogeneous expression systems, both
human and murine nyctalopin were determined to be anchored to
the cell surface [7,8]. Phosphatidylinositol-phosphalipase D (PI-
PLD), which specifically cleaves GPI anchors, was able to release
human nyctalopin from the cell surface, but not mouse nyctalopin
[7]. In addition, hydrazine, which is an inhibitor of GPI cleavage
and forms complexes with GPI anchored proteins, does not
complex with murine nyctalopin. These data suggest that murine
nyctalopin is anchored to the cell surface by a mechanism other
than a GPI anchor, possibly via transmembrane domains.
The predicted signal sequence in nyctalopin indicates it is likely
processed by a co-translational mechanism. Co-translational
targeting is mediated by the ribonucleoprotein complex (RNC),
the signal recognition particle (SRP) and its cognate membrane-
associated receptor (SR) located on the ER (reviewed in [9,10]).
Membrane proteins are inserted into the ER membrane either as
type I or type II membrane proteins. Type I and II membrane
proteins have their N-terminus located in the ER lumen or the
cytoplasm, respectively. The orientation in the membrane of the
first transmembrane domain is determined by three factors. First,
proteins with stable N-terminal tertiary structures tend to stay in
the lumen of the ER because they are too large to traverse the
translocon [11]. Second, the charge distribution either before or
between the transmembrane domains are important (reviewed in
[12]). If the region is positively charged then the intermembrane
region tends to remain in the cytosol. Third, longer hydrophobic
regions favor localizing the N-terminus in the lumen of the ER
[13,14].
Once translation and membrane insertion is complete in the
ER, the proteins are sorted and transported to the appropriate
sub-cellular compartment using a complex series of events that
occur in the Golgi network. Trafficking of the proteins from the
ER to the Golgi relies on the coatomer protein complex II (COPII)
and the adaptor protein (AP) – clathrin complexes (AP-clathrin
complexes) (reviewed in [15,16]. Transport of proteins from the
Golgi to the plasma membrane or the endosomes is done by
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(reviewed in [17]).
SLRP family members have diverse membrane orientation and
sub-cellular localization, which reflects their functional diversity.
Some members such as the TrK family of nuclear receptors are
integral membrane proteins [18]. Others, like Drosophila connectin
are GPI anchored [19] and the ribonuclease inhibitors are
localized to the cytoplasm [20]. In addition, solution X-ray
scattering experiments show that both decorin and biglycan are
dimers in solution and crystal structures predict that they form
dimers via interaction through their concave faces [21,22,23]. Gel
filtration chromatography, light scattering and sedimentation
equilibrium experiments indicate opticin also forms dimers [24].
These data suggest that the biologically active form of decorin,
opticin and biglycan may be a dimer.
In this report, we used a combination of yeast two-hybrid and
in-vitro translation approaches to investigate whether murine
nyctalopin is oriented with the N-terminus in the extracellular
space and if it is anchored to the membrane by a single
transmembrane domain. We also examined whether nyctalopin
could form homo-dimers in yeast.
Results
Topology of Murine Nyctalopin
Nyctalopin was predicted to be bound to the membrane by a
GPI anchor in human [1,2] and have two transmembrane
domains in rodents [6]. Expression in cultured cells provided
some experimental support for these predictions, although the
mechanism and orientation of murine nyctalopin was less certain
[7,8].
Sequence analyses of murine nyctalopin using seven different
topology prediction programs (HMMTOP2.0, [25]; TMPred,
[26]; TopPred2, [27]; SOSUI-Mp1, [28]; MemPype, [29];
TMHMM2.0, [30]; DAS, [31]) with the default parameters gave
a variety of results (Table 1). It can be seen that there is no
consensus with respect to the number and/or even the presence of
transmembrane domains in murine nyctalopin. Five of the seven
programs predicted a transmembrane domain at position 452–472
(TM1), three predicted a transmembrane domain at position 309–
328 (TM2) and one predicted a single transmembrane domain at
position 260–278 (TM3). Finally, DAS-TMfilter failed to identify
any transmembrane domains. TMHMM2.0 has strong support for
TM1 (probability of 0.9) and weaker support for TM2 probability
(0.6). From these analyses, there may be as many as three
transmembrane domains in murine nyctalopin (Figure S1). The
most support is for TM1 (452–472), then TM2 (309–328), and
there is a very weak support for TM3 (260–278) being a real
transmembrane domain. TM3 also is located within the LRR
domain, which is thought to be an interaction domain and
therefore unlikely to contain a transmembrane region.
Given the computational and experimental (see below) support
for the TM1 domain in murine nyctalopin, whereas human is
GPI-anchored, we examined the predicted mode of anchoring for
several other species. We used TMHH2.0 [30], big-PI [32] and
MemPype [29] prediction programs in an attempt to identify the
most likely location of transmembrane and GPI anchor sites, if
present, in nyctalopin sequences from several species (Figure 1).
These data showed that of the 9 mammals in the data set, the
murine sequence has by far the most support for a transmembrane
domain (TMHHM2.0, probability of ,0.9) and rat had moderate
(,0.6) support for a transmembrane domain. The remaining
species had very weak (,0.2) support for a transmembrane
domain, although MemPype predicted a transmembrane domain
in the rabbit sequence. Big-PI showed weak support for a GPI-
anchor in all the sequences. MemPype predicted transmembrane
domains in 3 species and GPI anchors in 8 species (Figure 1).
Given human nyctalopin has been shown to be GPI anchored [7],
it is clear that experiential data is required to confirm the methods
by which nyctalopin is anchored in each species.
Nyctalopin’s Leucine Rich Repeat (LRR) Domain is
Oriented into the Extracellular Matrix
To examine the membrane topology of murine nyctalopin, we
used a membrane split ubiquitin yeast two hybrid system (MYTH).
The MYTH system is based on the ability of the N- and the C-
terminal domains of ubiquitin, referred to as NubI and Cub,
respectively, to interact even when they are two separate peptides
[33,34,35]. Bait proteins are fused to Cub, which also is fused to
the LexAVP16 transcription factor. Prey proteins are fused to
either the NubI or its mutated form; NubG; which has an I13G
mutation. This substitution makes the reconstitution of functional
ubiquitin dependent on the interaction of the bait and prey fusion
proteins.When Cub-LexA-VP16 and NubI are present in the
cytoplasm, the two ubiqutin domains interact, reconstituting
ubiquitin. The reconstituted ubiquitin is recognized by ubiquitin
proteases (only present in the cytoplasm), which releases
LexAVP16 that translocates to the nucleus and activates
transcription of target selectable and/or marker genes.
To determine if nyctalopin was inserted into the membrane in
yeast we transformed yeast with EYFP-Cub, Nyc-Cub or Alg5-
Cub (a known membrane bound protein, [36]) (Figure 2A) and
determined if they were membrane bound. Immunohistochemical
analysis of the expression pattern showed that EYFP-Cub is
Table 1. Transmembrane (TM) domain predictions for murine nyctalopin.
Location of TM
Program #TM(s) C-terminus N-terminus TM3 TM2 TM1
HMMTOP2.0 3 Out In 260–278 309–328 452–473
TMPred 2 In/Out In/Out None 309–329 453–473
TopPred2 2 In/Out In/Out None 309–328 455–471
SOSUI-Mp1 1 In Out None None 452–473
MemPype 1 In Out None None 452–472
TMHMM2.0 2 Out Out None 309–329(0.6) 455–473(0.9)
DAS 0 None Out None None None
doi:10.1371/journal.pone.0033137.t001
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(Figure 2B). To confirm this biochemically, we isolated membrane
and cytoplasmic fractions of yeast transfected with Alg5-Cub
(membrane bound positive control) and Nyc-Cub. As with the
Alg5 control, nyctalopin is also localized to the membrane fraction
(Figure 2B).
After confirming that nyctalopin was properly targeted to the
membrane in yeast cells, we explored its orientation using the
MYTH system. As a positive control, we attached Cub-VP16LexA
to the C-terminus of the G-protein coupled receptor, GRM6, the
C-terminus of which is localized to the cytoplasm (Figure 3A). To
determine the orientation of nyctalopin, we attached the Cub-
VP16LexA-domain to either the C-terminus (Nyc-Cub) or the N-
terminus (Cub-Nyc) of nyctalopin (Figure 3A). To generate a prey
protein with known sub-cellular location, we attached NubI to the
C-terminus of the yeast plasma membrane protein; uracil
permease (Fur4) (Figure 3A). Fur4 is known to orient in the
plasma membrane with both C- and N-termini in the cytoplasm
[37]. Co-transformation of Grm6-Cub and Fur4-NubI shows that
Cub and NubI interacts, as indicated by growth on SD-LWHA
Figure 1. Sequence alignment of the carboxy termini of nyctalopin from several species. Predictions are based on data from the
MemPype prediction site (http://mu2py.biocomp.unibo.it/mempype). Putative transmembrane domains are underlined and the amino acids to which
the GPI is predicted to be attached are boxed. Shaded amino acids are those that differ from the consensus sequence. The most likely mode of
membrane anchoring is indicated on the right side of the figure. The alignment was created using ClustalW implemented in the Lasergene software
package (DNAStar Inc, Madison, WI). Accession numbers of sequences used for the alignment were : Mouse, AAM47034; rat, NP_001094437 ;human,
AAG42685; Chimpanzee, XP_001138632 ; Orangutan, XP_002831599.1; Gibbon, XP_003271059; Rhesus monkey, XP_001087613; Domestic cow,
XP_002700268; rabbit, XP_002719884; Zebrafish, ABB03696; Xenopus, NP_001087744; Anolis, XP_003219032; and zebrafinch, XP_002190541.
doi:10.1371/journal.pone.0033137.g001
Figure 2. Nyctalopin is membrane bound in yeast. A. Schematic diagram of constructs used to determine the localization of nyctalopin in
yeast. Nyc-Cub (109.4 kDa) is a fusion protein with the yeast invertase signal sequence (SUC) (20aa), EYFP (217aa), nyctalopin (453aa) and the Cub-
LexAVP16 artificial transcription factor (350aa). Alg5-Cub (77.5 kDa) is a yeast ER membrane bound protein fused to Cub-LexAVP16 and is used as a
positive control. EYFP-Cub has EYFP fused to Cub-LexAVP16. B. (Left) Confocal images of yeast strain BY4741 expressing either EYFP-Cub or Nyc-Cub
showing that EYFP-Cub is in the cytoplasm and Nyc-Cub is localized to the plasma membrane. B. (Right) Western blot of membrane (M) and cytosolic
(C) fractions from yeast strain NMY32 transfected with control plasmid (Alg5-Cub), untransfected cells or Nyc-Cub. These data indicate nyctalopin is
membrane bound.
doi:10.1371/journal.pone.0033137.g002
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row 1). In contrast, only when Cub-VP16LexA was attached to the
C-terminus of nyctalopin was interaction detected (Figure 3B, row
2 compared to row 3). These data show that nyctalopin is oriented
such that the C-terminus is intracellular. Nyctalopin also does not
have two transmembrane domains, because if this was the case
both C-and N-termini would be either intra- or extra-cellular. If
both termini were intracellular, Nyc-Cub and Cub-Nyc would
both interact with NubI. Similarly if both were extracellular
neither would interact. The results (Figure 3B) do not support
either conclusion, indicating nyctalopin does not contain two
transmembrane domains.
Computer predictions indicated the most likely location of the
transmembrane domain was from amino acid 452–472. To
examine this prediction, we made a deletion mutant (NycDTM1)-
Cub and also substituted a hydrophilic arginine for leucine at
position 463 within the predicted TM1 (NycL463R-Cub)
(Figure 4A). Using the membrane prediction program TMHMM
this L463R mutation in nyctalopin reduces the probability of a
membrane domain being present from ,0.9 to 0.1. If TM1 is the
only transmembrane domain, then both mutant proteins should be
secreted into the lumen of the ER. This will prevent interaction of
the attached Cub with Fur4-NubI, which is localized to the plasma
membrane with both termini in the cytoplasm. The bait plasmids,
Nyc-Cub and the two mutant constructs, were each co-transfected
with three different prey vectors (Figure 4B). Fur4-NubI was used
to test for membrane insertion and orientation. Fur4-NubG was
used to test for specificity of interaction between Cub and NubI,
and a control vector expressing only NubG was used to test for
self-activation (Figure 4A, Prey). Figure 4B shows that all plasmids
are incorporated into the yeast and express the selectable markers.
Only the parental Nyc-Cub/Fur4-NubI combination show any
growth or b-galactosidase expression on the quadruple drop out
plates (Figure 2B). These data indicate that the mutant Nyc-Cub
constructs are not inserted into either the ER or plasma
membrane, or released into the cytoplasm. This conclusion
assumes that the deletion and mutation constructs were expressed.
This was confirmed by analyzing yeast extracts by western blot,
using antibodies to LexA. In all cases the bait protein was present
at the expected size and at quantitatively similar expression levels
(Figure 4C).
The failure of the combination of Nyc-Cub/NubG to grow or
express b-galactosidase suggests that murine nyctalopin is not GPI
anchored. If it was, the carboxy Cub-VP16LexA would have been
cleaved and this alone would have supported growth and b-
galactosidase expression.
Murine Nyctalopin does not Homodimerize in Yeast
Several members of the SLRP family including decorin, opticin,
and biglycan have been shown to dimerize through their LRR
Figure 3. The N-terminus of nyctalopin is located in the extracellular space. A. Schematic diagrams of constructs used to determine the
orientation of nyctalopin in the yeast membrane. Bait constructs use the yeast invertase (SUC) signal sequence. In the schematic, the blue rectangle
represents the invertase signal sequence (SUC), the grey rectangle EYFP, the aqua ovals each LRR domain, the aqua rectangle with predicted
transmembrane (TM) domain (orange rectangle) , the chevron represents the C-terminus of ubiquitin (Cub) and the green rectangle represents the
artificial transcription factor (VP16LexA). Cub-Nyc has CubLexAVP16 inserted between the SUC signal sequence and nyctalopin. B. Membrane yeast
two hybrid analysis of nyctalopin orientation in the membrane. Plasmid incorporation (column 1) is confirmed by growth on SD/-LW plates. When
NubI and CubLexAVP16 are both localized to the cytoplasm, interaction occurs and supports growth on SD/-LWHA media and expression of b-
galactosidase. Grm6-Cub is used as a positive control. The lack of growth when Cub-Nyc and Fur4-NubI are co-expressed indicates that the N-
terminus of nyctalopin is not in the cytoplasm. Growth and expression of b-galactosidase when Nyc-Cub and Fur4-NubI are co-transformed indicate
the C-terminus of nyctalopin is localized in the cytoplasm.
doi:10.1371/journal.pone.0033137.g003
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yeast, we cloned full length nyctalopin with its signal sequence
replaced by the S. cerevisiae invertase signal sequence (SUC) into the
prey vector pDL2N-SUC. This fuses NubG to the C-terminus of
nyctalopin (Nyc-NubG) (Figure 5A). We used synaptophysin-Cub
(Syp-Cub) and synaptophysin-NubG (Syp-NubG), which have
been shown to form dimers using the MYTH system [39] as a
positive control. The Alg5-Cub and Alg5-NubG combination was
used as a negative control. Interactions between bait and prey
vectors were tested by growth on SD-LWHA plates as well as the
X-gal assay. The synaptopysin bait/prey combination showed
both growth and expression of b-galactosidase as expected.
However, neither the Alg5 nor the nyctalopin bait and prey
combinations showed either growth or expression of b-galactosi-
dase (Figure 5B). These data indicate that nyctalopin does not
form dimers in yeast.
The LRR Domain of Nyctalopin is Extracellular
One of the limitations of the topology experiments in yeast is the
fact that to obtain optimal expression of murine proteins, we had
to replace the nyctalopin signal sequence with the S. cerevisiae
invertase signal (SUC) sequence. This could potentially alter the
topology of nyctalopin. To provide additional support for the
proposed topology we used a mammalian based in vitro
transcription/translation system to evaluate post translational
processing directly. Detection of the translated proteins in the
system is based on incorporation of biotinylated lysine-tRNA
(transcend tRNA), which is incorporated by the addition of
precharged epsilon-labeled tRNA. This allows the use of
streptavidin conjugated horseradish peroxidase (Strep-HRP) or
streptavidin conjugated alkaline phosphatase (Strep-AP) for
detection of newly synthesized protein on western blots. Nyctalo-
pin only contains 2 lysines, therefore luciferase, which contains 40
lysines, was inserted after the nyctalopin signal sequence (SS) to
increase detection sensitivity (SLucNyc) (Figure 6A). This should
not disrupt function because insertion of EYFP at the same
location generated a fully functional fusion protein [3]. A second
vector with luciferase fused to the C-terminus of nyctalopin
(SNycLuc), also was constructed (Figure 6A). A plasmid containing
only luciferase was used as a positive control.
First, we determined if nyctalopin is co-translationally processed
by translating nyctalopin in the presence or absence of canine
microsomal membrane (CMM). Nyctalopin is predicted to contain
a signal sequence and with the N-terminus located in the lumen of
Figure 4. Genetic analysis shows murine nyctalopin has a single transmembrane domain. A. Schematic diagram of bait and prey
constructs used to dissect the topology of nyctalopin. In the schematic, the blue rectangle represents the invertase signal sequence (SUC), the grey
rectangle EYFP, the aqua ovals each LRR domain, the aqua rectangle with predicted transmembrane (TM) domain (orange rectangle) the C-terminus
of nyctalopin, the chevron the C-terminus of ubiquitin (Cub) and the green rectangle the artificial transcription factor VP16LexA. NycDTM-Cub has
amino acids 455–476 (containing TM1) deleted from nyctalopin. NycL463R-Cub has a base substitution that creates a leucine to arginine substitution
at position 463 of nyctalopin. Bi. Shows that all bait and prey plasmids were present in the NMY32 yeast strain and supported growth on the selective
SD/-LW plates. Bii. The growth tests for interaction of bait and prey fusion proteins when the transformants are grown on SD/-LWHA plates. Biii. An X-
gal assay for expression of b-galactosidase confirming the interaction in Bii. These results support the conclusion that only the Nyc-Cub/Fur4-NubI
combination interact, indicating that there is a transmembrane domain in nyctalopin and that the C-terminus of nyctalopin is cytoplasmic. C. Western
blot showing truncated transmembrane and L463R mutants are expressed in NMY32 yeast strain.
doi:10.1371/journal.pone.0033137.g004
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obtain robust translation, addition of CMM was required
(Figure 6B, last lane). We next determined the orientation of
nyctalopin using proteinase K digestion. If the N-terminus of
nyctalopin is in the lumen of the microsomes as predicted, it
should be protected from proteinase K digestion. Both SLucNyc
and SNycLuc were tested in the coupled translation/transcription
assay, with subsequent digestion by proteinase K. Figure 6C shows
that there is no digestion of SLucNyc, whereas SNycLuc was
digested by proteinase K. Protection for SLucNyc was lost when
CHAPS was added. These results indicate that the N-terminus of
nyctalopin is protected: and therefore is localized to the lumen of
the microsomes and the C-terminus of nyctalopin is in the
cytoplasm.
The experiment using proteinase K shows that the N-terminus
is protected from digestion. However, after sufficient time
proteinase K can digest all proteins even in the absence of
CHAPS. To independently confirm that nyctalopin is oriented
with the N-terminus in the lumen of the ER and the C-terminus in
the cytoplasm, we used a second protease, thrombin, to examine
membrane orientation of nyctalopin after in vitro translation. There
are two thrombin cleavage sites in SLucNyc, one at position 659
and the other at position 972 (Figure 6A). The yeast two hybrid
and proteinase K protection data above suggest that the N-
terminus containing luciferase should be in the lumen of the
microsomes and therefore protected from thrombin cleavage.
Figure 6D shows that in the presence of intact microsomes,
SLucNyc is protected from thrombin digestion. However, when
the microsomes are disrupted by adding CHAPS, the protection is
lost as can be seen by the generation of the 72.8 kDa cleavage
product (Figure 6D, bottom arrow) and the disappearance of the
113 kDa SlucNyc band (Figure 6D, upper arrow). These data
indicate that nyctalopin is oriented with the LRR domain in the
lumen of the ER, which will result in this domain being present in
the extracellular space once mature vesicles containing nyctalopin
are fused with the plasma membrane (Figure 6E).
Discussion
In the dark, photoreceptors release glutamate tonically into the
synaptic cleft. The glutamate released binds to the metabotropic
glutamate receptor (GRM6) on DBCs [40,41] or the AMPA/
kainate receptors on hyperpolarizing bipolar cells [42,43,44].
Glutamate binding to the GRM6 receptor activates a G-protein
signal transduction cascade that closes a non-selective cation
channel on the depolarizing bipolar cells [45,46,47], recently
identified as TRPM1 [48,49,50]. When there is an increase in light
intensity, glutamate release from photoreceptors is decreased,
which leads to reduced GRM6 receptor activity, inactivation of
the G-protein cascade and opening of the TRPM1 channel,
causing depolarization of the DBCs. The depolarization is seen in
an electroretinogram as a positive going b-wave. Defects in this
signaling cascade result in loss of the ERG b-wave, and a class of
human diseases called complete congenital stationary night
blindness (CSNB) or CSNB1. Previous data showed that mutations
in nyctalopin predicted to cause a loss of nyctalopin in humans and
Figure 5. Nyctalopin does not form homo-dimers in yeast. A. Schematic of bait and prey constructs used. The components of nyctalopin are
as described in Fig. 1 and 2. Alg5, Asparagine-linked glycosylation 5, is a yeast ER membrane bound protein with both the C-terminus and N-terminus
in the cytoplasm. Syp-Cub and Syp-NubG are bait and prey constructs with synaptophysin, which is known to dimerize, and is used as positive
control. B. Growth indicating incorporation of both bait and prey plasmids into yeast. Interaction was determined by growth on SD/-LWHA media and
expression of b-galactosidase. These data show that nyctalopin does not form dimers in this system.
doi:10.1371/journal.pone.0033137.g005
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indicating signaling between the GRM6 receptor and TRPM1 is
defective. Our topological analyses of nyctalopin show that the
entire LRR domain is in the extracellular space, suggesting that
this domain cannot be directly involved in the intracellular
trimeric G-protein signaling cascade. Murine nyctalopin is
predicted to have as many as 5 amino acids within the cytoplasm;
so in theory these could interact with other components of the
cascade. However, given human nyctalopin is thought to be GPI
anchored, and therefore lacking this region, we suggest it is
unlikely that the intracellular amino acids in murine nyctalopin
have any function. Experiments such as truncation of these amino
acids and subsequent functional analyses would, however, be
needed to confirm this point. Further, our recent data and that of
others indicate that nyctalopin interacts directly with TRPM1
[51,52] and is required to localize TRPM1 to the tips of DBCs.
LRR domains have been shown to be involved in protein-
protein interactions in several SLRP family members [4,53,54,55]
and other proteins (for review see ref [56]). That this domain is
critical to function in nyctalopin is highlighted by the fact that
mutations in the LRR domain of nyctalopin in humans cause
CSNB1 [1,2]. These data, combined with our observation that
nyctalopin is required for the localization of TRPM1 to the
dendritic tips of DBCs [52], suggest several possible mechanisms of
action. Functional TRP channels are homo or hetero tetramers
(for reviews see [57,58]). Therefore, it is possible that nyctalopin is
required for stabilization of the tetrameric structure in the
membrane. In support of this, decorin, which is a close relative
of nyctalopin, has been shown to interact with epidermal growth
factor (EGF) receptor, causing dimerization and subsequent
internalization of the EGF [59,60]. The detailed mechanism of
action of nyctalopin will require detailed dissection of the protein
protein interaction domains as well as the predicted glycosylation
of nyctalopin, although its functional form does not appear to be a
dimer, at least in yeast.
In this report we have shown that murine nyctalopin is a
transmembrane protein. In contrast human nyctalopin is anchored
to the membrane by a GPI moiety [7]. Further experimental
analyses will be required to determine which combinations of
amino acid substitutions in murine nyctalopin compared to human
Figure 6. The N-terminus of nyctalopin is in the lumen of the ER. A. Schematic of constructs used to determine the orientation of nyctalopin
in the membrane of the endoplasmic reticulum. SLucNyc (113 kDa) has luciferase (yellow rectangle) inserted after the murine nyctalopin signal
sequence (SS). SNycLuc has luciferase attached to the C-terminus of full length nyctalopin. The arrows indicate the two thrombin (Thr) cleavage sites.
Thrombin cleavage will generate 72.8 kDa and 34.4 kDa peptides, however, only the 72.8 kDa peptide will be labeled with biotinylated lysine and
detected on a western blot. B. Western blot of in vitro transcription/translation reaction showing that without canine microsomal membranes (CMM),
nyctalopin is not expressed. These data indicate co-translational processing and membrane insertion of nyctalopin in the ER. C. Expression of either
SLucNyx or SNycLuc and treatment with proteinase K in the presence or absence of CHAPS. Lanes 1–4 indicate robust expression of full length
nyctalopin. Lanes 5–8 show that SNycLuc but not SLucNyc is degraded by proteinase K, indicating the N-terminus of nyctalopin is in the ER lumen
and therefore protected from degradation. Addition of CHAPS (0.5%) (lanes 9–12) disrupts the membranes and results in proteinase K digestion of
both nyctalopin fusion proteins. D. Western blot of lysates from in vitro translation reactions, control (lanes 1–2), or when SLucNyc was included and
after thrombin digestion alone (lanes 3–5) or thrombin digestion in the presence of 0.5% CHAPS (Lanes 6–8). Disruption of microsomal membranes
with CHAPS allows cleavage of the fusion protein demonstrating that the N-terminus of nyctalopin is protected, and is therefore located in the lumen
of the ER. Note the disappearance of the 113 kDa bands and the appearance of the 72 kDa band. E. Schematic showing a model of the orientation of
nyctalopin in the ER and it’s subsequent disposition on the plasma membrane.
doi:10.1371/journal.pone.0033137.g006
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suggest that how nyctalopin is anchored to the membrane is not
critical to its function; rather it may be the structure of the
extracellular domain. Future studies to elucidate the proteins with
which nyctalopin interacts, and the critical regions of nyctalopin
involved in these interactions will likely shed light not only on
nyctalopin , but also the role of LRR domains in many other
proteins.
Methods
Yeast Strains and Growth Media
Yeast strains used in this study are NYM32 (MATa his3 D 200
trp1–901 leu2–3,112 ade2 LYS2::(lexAop)4-HIS3 URA3::(lex-
Aop)8-lacZ (lexAop)8-ADE2 GAL4)) and BY4741 (MATa; his3D1;
leu2D0; met15D0; ura3D0) strains. The growth media used is
synthetic media lacking leucine, tryptophan (SD/-LW), and
leucine, tryptophan, histidine and adenine (SD/-LWHA) (Clon-
tech, Moutain View, CA). All transformations were done using the
lithium chloride method (Clontech, Moutain View, CA).
Ethical Statement
This study was carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Institutional Animal Care and Use
Committee of the University of Louisville (Protocol Number
10065). Retinas were removed for RNA isolation after euthanasia
of adult C57BL/6J mice by carbon dioxide inhalation followed by
cervical dislocation, as recommended by the American Veterinary
Medical Association.
Plasmid Constructs for Topology Experiments
Full length cDNA representing nyctalopin was obtained by
PCR using cDNA synthesized from mRNA isolated from retinas
of adult C57BL/6J mice. Vectors were constructed using infusion
cloning techniques (Clontech, Moutain View, CA). For membrane
topology experiments, the yeast membrane two hybrid (MYTH)
system (Dualsystems, Grabenstrasse, Switzerland) bait vectors,
pCCW-SUC, pNCW, pAI-Alg5, and prey vector, pDL2Nx, were
used. Enhanced yellow fluorescent protein (EYFP) cDNA was
cloned into the PstI site of pCCW-SUC yielding EYFP-Cub. Nyc-
Cub was made by inserting the nyctalopin cDNA encoding amino
acids 23–476 of nyctalopin into the SfiI site of Eyfp-Cub, which
fused the C-terminus of nyctalopin to the C-terminal domain of
ubiquitin (Cub) and the synthetic transcription factor (LexAVP16).
To generate Cub-Nyc, the signal sequence of the yeast invertase
gene was cloned into the XbaI site of pNCW. Nyctalopin cDNA
encoding amino acids 23–476 was cloned into the PstI site of
pNCW. Grm6-Cub was made by cloning a full length Grm6
cDNA without its signal sequence into the SfiI site of pCCW-SUC.
Fur4-NubI was made by digesting pAI-Alg5 with SpeI and ClaI
restriction enzymes to remove the Alg5 gene and inserting the Fur4
gene. Alg5-NubG was made by digesting pAI-Alg5 with AgeI and
XhoI, which removes the N-terminus of ubiquitin (NubI) from the
pAI-Alg5 vector. NubI was replaced by a PCR product in which
the substitution, I13G was introduced to produce Alg5-NubG.
Fur4-NubG was made by cloning the Fur4 gene into the pDL2Nx
prey vector.
Nyctalopin dimerization was assayed by cloning full length
nyctalopin cDNA into the SfiI site of pDL2Nx, creating Nyc-
NubG. As a positive control, cDNA encoding synaptopysin (Syp)
was cloned into the SfiI site of the pCCW-Ste and pDL2N-Ste,
creating Syp-Cub and Syp-NubG, respectively.
For mutagenesis experiments, NycDTM3-Cub was created as a
deletion variant of Nyc-Cub. This construct had nyctalopin amino
acids 455–476 deleted. NycL463R-Cub had a single amino acid
substitution in predicted transmembrane domain 1 (TM1).
Constructs used in the in vitro Transcription/Translation
Experiments
SNycLuc was made by inserting a full length nyctalopin cDNA
into the BamHI site of the T7 Luciferase Control vector (Promega,
Madison, WI). This arrangement fused luciferase to the C-
terminus of nyctalopin. For the SLucNyc, the T7 luciferase vector
was re-engineered so that the nyctalopin signal sequence was fused
to luciferase, which was fused to amino acids 23–476 of
nyctalopin. This arrangement put luciferase at the N-terminus of
nyctalopin between the nyctalopin signal sequence (amino acids 1–
22) and the rest of nyctalopin (amino acids 23–476).
Colony Lift Assay
To determine if b-galactosidase was expressed, a single yeast
colony was picked from a selection plate, streaked onto a new
synthetic dropout (SD) plate (SD/-LW) and incubated for 2 to
3 days at 30uC. A Whatman 3 MM filter paper was placed
directly onto the agar plate in contact with the yeast colonies for
10 min, carefully removed and transferred into liquid nitrogen for
2 min to lyse the cells. The filter paper was thawed for 5 min at
room temperature, then incubated in freshly prepared agarose X-
gal mix (0.5% agarose in 1xPBS, containing 0.1 mg/ml X-gal).
Incubation at room temperature was for either 8 hours or until a
blue color developed.
Immunohistochemistry
Yeast were grown to mid-log (OD600=0.5–0.75) and fixed in
PBS containing 2% glucose, 4 mM EGTA, and 7.4% formalde-
hyde, for 1 hour. The cells were recovered by centrifuging at
30006g for 5 min and washed twice in PS-Buffer (0.1 M NaPO3,
pH 6.6, 1.2 M sorbitol). To make spheroplasts, cells were
incubated for 15 min in PS-buffer containing 7.1 mM b-mercap-
toethanol and zymolyase (50 U/ml) at 37uC. After two washes in
PS-buffer, cells were added to polylysine coated glass microscope
slides, incubated at room temperature for 15 min and washed in
PS-buffer three times. The cells were permeabilized in P-buffer
(10 mg/ml of BSA, 0.5% SDS in PBS) for 15 min, washed ten
times in PBS/BSA Buffer (10 mg/ml BSA in PBS) and then
blocked for 1 hour in this same buffer. At the end of blocking, cells
were washed five times in PBS/BSA buffer by applying the buffer
and aspirating. To stain cells, Alexa 488 conjugated anti-GFP
antibody (Cat #: A2131, Invitrogen, Carlsbad, CA) was diluted
1:1000 in PBS/BSA and incubated overnight in a moist chamber.
Slides were washed ten times with PBS/BSA-Buffer followed by
three times in PBS, then allowed to air dry at room temperature
before cover slipping. Images were taken on an Olympus FV300
Confocal Microscope using a 60x objective and images were
processed using Flowview software.
In vitro Translation and the Protection Assays
In vitro transcription and translation were done according to the
manufacturer’s protocol (Promega, Madison, WI, Cat # TM035).
Plasmid DNA (2 mg) was added to each translation reaction. To
maximize the translation of membrane proteins, canine micro-
somal membranes (Cat # Y4041 Promega, Madison, WI) were
added to some samples. After 90 min incubation at 30uC, 2 mlo f
the translation mix was added to 13 ml of SDS sample buffer and
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NOVEX gradient PAGE gels (Invitrogen, Calsbad, CA).
To determine the orientation of proteins in the membrane,
10 ml of translation product was incubated with or without 0.1 mg
of proteinase K (20 mg/ml). Samples were incubated on ice for 5,
10, 15, 20 min with or without the addition of Chaps (0.5%).
The thrombin cleavage mix contained; 16thrombin cleavage
buffer, 10 mg of total protein lysate, and thrombin (50 U) in a final
volume of 50 ml. Samples were incubated at 20uC for 16 hours.
20 ml of the digested samples were added to 20 ml of SDS buffer,
heated at 70uC and resolved by PAGE on 4–12% NOVEX
gradient gels.
Supporting Information
Figure S1. Tertiary structure of murine nyctalopin and
theoretical orientation. A. The convex side of nyctalopin
consists of parallel b-sheets and the concave side a-helices. The b-
sheets and a-helices are folded to form 11 tandem leucine rich
repeats, which are capped at the N- and C-termini by cysteine rich
repeats. The N-terminus has a predicted signal sequence and the
C-terminus has one or more predicted transmembrane domains.
B. Possible orientations of nyctalopin dependent on whether there
are three (I), two (II and III) one (IV) or no (V) transmembrane
domains in nyctalopin.
(TIF)
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